STOCK TITAN

Insider to sell 26,250 SLDB shares on NASDAQ (NASDAQ: SLDB)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of SLDB common stock, Paul Herzich, has filed a notice of intent to sell up to 26,250 shares through E*TRADE on the NASDAQ, with an aggregate market value of $168,968.63. The issuer had 82,561,235 shares outstanding and the approximate sale date is February 2, 2026.

The shares to be sold were acquired on February 2, 2026 via settlement of performance shares from the issuer as compensation. Over the prior three months, Herzich sold 2,701 shares of common stock on December 3, 2025, generating gross proceeds of $13,802.11.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many SLDB shares is Paul Herzich planning to sell under this Form 144?

Paul Herzich filed to sell up to 26,250 shares of SLDB common stock. These shares have an aggregate market value of $168,968.63 and are planned for sale on or around February 2, 2026 through E*TRADE on the NASDAQ exchange.

How did Paul Herzich acquire the SLDB shares he plans to sell?

The 26,250 shares were acquired on February 2, 2026 through settlement of performance shares from the issuer as compensation. This means the stock was received as part of an incentive arrangement rather than purchased for cash in the open market.

What recent SLDB stock sales has Paul Herzich made before this planned transaction?

During the prior three months, Paul Herzich sold 2,701 shares of SLDB common stock on December 3, 2025, for $13,802.11 in gross proceeds. This earlier sale is disclosed alongside the new planned sale in the same Form 144 notice.

How large is this planned SLDB sale relative to shares outstanding?

The notice lists 82,561,235 shares outstanding for the issuer’s common stock. The planned sale of 26,250 shares is small compared with this baseline figure, indicating the transaction represents only a minor portion of total outstanding shares.

Through which broker and market will the SLDB shares be sold?

The planned sale will be executed through ETRADE FINANCIAL CORPORATION, with the shares to be sold on the NASDAQ exchange. The Form 144 lists E*TRADE’s address in Alpharetta, Georgia, and specifies NASDAQ as the trading venue for the common stock.

What representation does the seller make about inside information in this SLDB Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. This representation is a standard requirement associated with Form 144 sales.
Solid Bioscience

NASDAQ:SLDB

View SLDB Stock Overview

SLDB Rankings

SLDB Latest News

SLDB Latest SEC Filings

SLDB Stock Data

736.95M
65.05M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
CHARLESTOWN